Key Takeaways RMD posted Q2 EPS of $2.81, up 15.6% year over year, beating consensus alongside 11% revenue growth.Resmed expanded adjusted gross margin to 62.6% and operating margin to 36.6%, as profit outpaced costs.RMD saw double-digit growth in Sleep and Breathing Health, while Residential Care Software rose 6.6%.Resmed Inc.’s (RMD) adjusted earnings per share (EPS) in the second quarter of fiscal 2026 were $2.81, up 15.6% year over year. The metric beat the Zacks Consensus Estimate by 4.59%.The adjustme ...